Precigen Operating Cycle from 2010 to 2026

PGEN Stock  USD 4.88  0.33  6.33%   
Precigen Operating Cycle yearly trend continues to be very stable with very little volatility. Operating Cycle is likely to drop to 92.47. During the period from 2010 to 2026, Precigen Operating Cycle quarterly data regression pattern had sample variance of  109,261 and median of  113.02. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
97.34
Current Value
92.47
Quarterly Volatility
330.54617518
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Precigen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Precigen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.9 M, Interest Expense of 6.6 K or Total Revenue of 3.4 M, as well as many indicators such as Price To Sales Ratio of 72.19, Dividend Yield of 0.0 or PTB Ratio of 4.58. Precigen financial statements analysis is a perfect complement when working with Precigen Valuation or Volatility modules.
  
Build AI portfolio with Precigen Stock
Check out the analysis of Precigen Correlation against competitors.
To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.
Evaluating Precigen's Operating Cycle across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Precigen's fundamental strength.

Latest Precigen's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Precigen over the last few years. It is Precigen's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Precigen's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Very volatile
   Operating Cycle   
       Timeline  

Precigen Operating Cycle Regression Statistics

Arithmetic Mean240.60
Geometric Mean142.18
Coefficient Of Variation137.38
Mean Deviation194.65
Median113.02
Standard Deviation330.55
Sample Variance109,261
Range1.4K
R-Value0
Mean Square Error116,545
R-Squared0.00000104
Significance1.00
Slope0.07
Total Sum of Squares1.7M

Precigen Operating Cycle History

2026 92.47
2025 97.34
2024 108.15
2023 92.35
2022 203.77
2021 52.87
2020 325.6

About Precigen Financial Statements

Precigen investors utilize fundamental indicators, such as Operating Cycle, to predict how Precigen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 97.34  92.47 

Pair Trading with Precigen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Precigen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precigen will appreciate offsetting losses from the drop in the long position's value.

Moving against Precigen Stock

  0.66VCYT Veracyte Earnings Call This WeekPairCorr
  0.6DRMA Dermata TherapeuticsPairCorr
  0.4OSE OSE Pharma SAPairCorr
  0.34RAC Race Oncology Earnings Call This WeekPairCorr
The ability to find closely correlated positions to Precigen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Precigen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Precigen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Precigen to buy it.
The correlation of Precigen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Precigen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Precigen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Precigen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Precigen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Precigen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Precigen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Precigen Stock:
Check out the analysis of Precigen Correlation against competitors.
To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Will Biotechnology sector continue expanding? Could Precigen diversify its offerings? Factors like these will boost the valuation of Precigen. Anticipated expansion of Precigen directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Precigen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.41)
Revenue Per Share
0.015
Quarterly Revenue Growth
0.194
Return On Assets
(0.67)
Return On Equity
(6.68)
Investors evaluate Precigen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Precigen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Precigen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Precigen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Precigen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Precigen's market price signifies the transaction level at which participants voluntarily complete trades.